• History, Mission, Vision, & Core Values
• Management
  • Founder
  • Employees
• Investors
• Careers
  • Posted Jobs
  • Internships
• Collaborative Business Model
• Location
• Contact Information
• Ordering Information
• Site Map

Mary Pat Moyer, Ph.D. Founder, President, CEO and Chief Science Officer, INCELL Corporation, LLC Founder and Technical Advisor, TEKSA Innovations Corp. Adjunct Professor, University of Texas Health Science Center at San Antonio and University of Texas at San Antonio

Dr. Mary Pat Moyer is a biomedical scientist, entrepreneur and technology business leader. She founded the innovative life sciences company, INCELL Corporation, LLC (1993; www.incell.com), after over 20 years as an academic scientist, as Director of the Center for Human Cell Biotechnology, Division Head of Surgical Research, and Professor of Surgery, Microbiology, Cellular and Structural Biology, Pediatrics, and Molecular Medicine at the University of Texas Health Science Center at San Antonio.  She received her Ph.D. in microbiology, emphasis in virology, from the University of Texas at Austin, and BS and MS degrees in biology from Florida Atlantic University. She is an advocate for accelerating development of products from the laboratory to the clinic. 

As CEO and Chief Science Officer, she has orchestrated INCELL’s growth in research and clinical products, pre-clinical testing services and R&D for new products, with 8 small business research grants awarded through NIH, and from the company’s self-generated corporate capital from sales of products and services in two major core technology areas of expertise: (1) Microbiology: Non-needle Vaccines and Infectious Disease and (2) Clinical Cell and Tissue Biotechnology: Cancer, Regenerative Medicine and Stem Cells. She is leading INCELL’s pioneering products combined with disruptive manufacturing and packaging technologies. These include customized human cell and tissue biotechnology applications, an adjunct cancer therapy to improve quality of life for cancer patients currently being enrolled at Johns Hopkins Medical Center in a trial sponsored by the National Cancer Institute; and oral and nasal vaccines against smallpox to be clinically tested in collaboration with the USAF and Army. Those vaccines are providing key platform technologies for influenza, HIV, tularemia, cancer, and other vaccines, as part of the Bio-Manufacturing Alliance Program (BIO-MAP), an initiative to accelerate manufacturing of reasonably priced biomedical products such as vaccines, antibodies, other therapeutics and medical devices. An authority in microbiology, cancer, biodefense, and stem cells, Dr. Moyer has published over 200 scientific papers and abstracts, co-authored a textbook “Colon Cancer Cells”, and has or serves as a Consultant to many national and international government agencies (e.g, WHO, NIH, NASA, DoD), universities and industry. She gives extensive professional and community service, is on many advisory boards and committees, and is a member of many scientific and business organizations. She was a founding member of the International Cord Blood Society, and has been or is a member of numerous scientific and research societies, including the American Assn for Cancer Research, the Society for In Vitro Biology, the International Society for Stem Cell Therapy, American Society for Neural Transplantation, the American Society for Microbiology, American Society for Virology, International Society for Stem Cell Therapy, and many more.

Dr. Moyer has received many awards, including: 1999 Ernst & Young Entrepreneur of the Year Award in “Life Sciences-Emerging Companies”, 1999 inductee into the national Entrepreneurs Hall of Fame; the 1999 Entrepreneurial Spirit Award from National Association of Women Business Owners, the SA Women’s Chamber of Commerce 1999 Entrepreneurial Woman of the Year Award, the ITEC 2000 Information Technology Achievement Award, and the Women’s Leadership Award 2000 from the San Antonio Business Journal. In 2001, she was selected as a Fellow of the internationally recognized IC2 Institute in Austin. In 2002 she received the “Breaking the Glass Ceiling Award” from the American Association of University Women, and the Governor’s Recognition Award for Texas Women in Leadership. Regional recognition in 2003 included “Faces of the Medical Community”, “Innovative Small Business Leader”, and UTSA Management of Technology awards. She was 1 of only 6 national executives selected to present INCELL’s corporate development, business model, and scientific work at the national NIH Small Business Innovative Research meetings in 2003 and 2004, and represented Texas at the 2003 national Research!America Stem Cells conference panel and debate in Austin, and at the 2005 Stem Cells Panel -Training Session of the Texas Legislature. In 2004 she received the Athena Award for Women in Leadership, the West SA Chamber of Commerce Doctoral Achievement Award, and was a Texas Workforce Investment Council (2004-08) Governor appointee. Since 2005, she has been a Board member for the International Centre for Infectious Disease of Canada. In 2006, she received the “Healthcare Hero” award for Biomedicine Innovation from the SA Business Journal, was selected to the Biodefense Product Development Working Group for NIH, received a recognition awards from the SA Ambassador Program, the Alamo Workforce Leadership Award for Innovation, and  was voted as one of the “2006 Ten Top Texas CEOs” of Texas Bio-Industry by Texas Healthcare and Bioscience Institute members, and was selected by the SA Women’s Chamber for a 2007 “Women of Voice and Vision” award. She was profiled in an article on Stem Cells in the SA Express-News and was interviewed by NPR, was a recognized as a case study chapter in a 2006 student textbook about entrepreneurship. She has been profiled in many other publications and news stories. As examples, in 2004 she was highlighted in Women CEO articles in San Antonio’s SA Woman magazine and in Genetic Engineering News (San Francisco), and the Biotech Today Show (San Diego). She is often selected to speak at regional, national, and international conferences, including science and biodefense conferences in Russia.

Dr. Moyer is Founder and President of the SanAntonio Austin Life Sciences Association (SALSA; www.bio-salsa.org) where she has chaired the Biodefense Summit for the past 6 years, works passionately as a technology community activist for Texas and San Antonio, Texas’ Technology Initiative Biotech Work Group Co-Chair and serves on the boards of many for-profit companies and not-for-profit organizations, including BioMedSA. She is also Founder and Advisor of TEKSA Innovations Corp. (1999; www.teksa.net), a consortium that is mentoring small businesses in life science, information technology and engineering as a means to implement the formation and growth of technology companies and to promote regional, national, and international economic development.  Her motto: “Be honest-- keep a spiritual center and sense of humor—and never-never give up!”